Show simple item record

dc.contributor.authorFrussa, R.
dc.contributor.authorMonteiro, M. D.
dc.contributor.authorSoares, CGS
dc.contributor.authorDecio, R. C.
dc.date.accessioned2016-01-24T11:40:08Z
dc.date.available2016-01-24T11:40:08Z
dc.date.issued1992-07-01
dc.identifierhttp://dx.doi.org/10.1159/000138973
dc.identifier.citationPharmacology. Basel: Karger, v. 45, n. 1, p. 58-60, 1992.
dc.identifier.issn0031-7012
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/25265
dc.description.abstractWe determined the effect of 13 days of treatment with 2.0 mg/kg haloperidol, 4.0 mg/kg bromocriptine or 2.0 mg/kg amphetamine on the number of tumor cells of mice bearing Ehrlich ascites carcinoma. the dopaminergic blocker significantly reduced the number of tumor cells of experimental mice, but the two dopamine-mimetic drugs used did not significantly affect tumor development. These results suggest that although neuroleptic drugs do inhibit Ehrlich ascites tumors, this effect does not seem to be related to changes in dopaminergic neuronal transmission.en
dc.format.extent58-60
dc.language.isoeng
dc.publisherKarger
dc.relation.ispartofPharmacology
dc.rightsAcesso restrito
dc.subjectHALOPERIDOLen
dc.subjectBROMOCRIPTINEen
dc.subjectAMPHETAMINEen
dc.subjectEHRLICH ASCITES CARCINOMAen
dc.titleEFFECTS of HALOPERIDOL, BROMOCRIPTINE and AMPHETAMINE ON the DEVELOPMENT of EHRLICH ASCITES-CARCINOMA in MICEen
dc.typeArtigo
dc.rights.licensehttp://www.karger.com/Services/RightsPermissions
dc.contributor.institutionSCH MED MARILIA
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationSCH MED MARILIA,DEPT PHYSIOL,MARILIA,BRAZIL
dc.identifier.doi10.1159/000138973
dc.description.sourceWeb of Science
dc.identifier.wosWOS:A1992JG42500008


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record